Search
for
Sort by
Research 691–720 of 772
- The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report
- Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment
- 53274 Real-world experience of efficacy and safety of baricitinib in Korean patients with severe alopecia areata
- 600 Impact of baricitinib on work productivity and indirect costs in adult patients with atopic dermatitis: A meta-analysis of clinical trials
- 013 IL-15/IL-15Rα signaling is a guardian of human hair follicle immune privilege and promotes hair growth
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Efficacy and Safety of Ritlecitinib in the Asian Subpopulation of the ALLEGRO ‐2b/3 and ALLEGRO ‐ LT Clinical Studies for Alopecia Areata
- Baricitinib in Alopecia Areata: Real-Life Changes in Lipid Profile and Hematologic Inflammation Indices at 52 weeks
- P88 Real-world evidence on efficacy and safety of Janus Kinase inhibitors in the treatment of moderate to severe active Ulcerative Colitis
- Baricitinib maintains regrowth of hair, eyebrows, and eyelashes over 3 years
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Oral Tofacitinib in Refractory Pediatric Alopecia Areata
- Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata
- Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two international randomized controlled trials
- Surgical Approaches for Repigmenting Vitiligo 2.0
- Comparative efficacy of oral Janus kinase inhibitors and biologics in adult alopecia areata: A systematic review and Bayesian network meta‐analysis
- Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
- Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis
- Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata
- Interleukin-15 is a hair follicle immune privilege guardian
- 0527 Effectiveness of janus kinase inhibitor for rapidly progressive acute alopecia areata
- Approach to Managing Recalcitrant Alopecia Areata with Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- “<i>Nomen Omen</i>: The Myth of God Janus”
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- Etrasimod for alopecia areata: The scenario for a less extensive and moderate form
- Wiederbehaarung bei einem Patienten mit Alopecia universalis und Psoriasis vulgaris unter Deucravacitinib‐Therapie
- Comparative characteristics of the effectiveness of drugs for the treatment of alopecia areata in childhood